Application of Imidazole As a Selective Inhibitor Thromboxane Synthetase in Human Platelets

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1977 Apr 1

PMID 193113

Citations 36

Authors

P NEEDLEMAN

A Raz

J A Ferrendelli

M Minkes

Affiliations

Soon will be listed here.

Abstract

Human platelet suspensions release a rabbit-aorta-contracting substance (previously identified as thromboxane A2) during aggregation produced by arachidonic acid, prostaglandin endoperoxide, thrombin, and collagen. Incubation of platelets with imidazole did not interfere with the aggregation produced by these agonists but markedly reduced the generation of the rabbit-aorta-contracting substance. We find that imidazole inhibited the conversion of exogenous or endogenous prostaglandin endoperoxide into thromboxane A2-Imidazole selectively inhibits thromboxane synthetase in intact human platelets, because this agent blocks the conversion of [14C]arachidonate into [14C]thromboxane B2 but does not inhibit the conversion of [14C]arachidonate into [14C]prostaglandin E2. The inhibition of thromboxane synthetase by imidazole is not the result of an alteration in platelet 3':5'-cyclic AMP levels. These results illustrate the utility of imidazole as a pharmacological tool and demonstrate the two unique and dissociable properties of the endoperoxides themselves--their ability to aggregate platelets and their enzymatic conversion to the potent vasoconstrictor thromboxane.

Citing Articles

The In Vitro and In Vivo Effect of Lipoxygenase Pathway Inhibitors Nordihydroguaiaretic Acid and Its Derivative Tetra--methyl Nordihydroguaiaretic Acid against 544.

Reyes A, Kim H, Huy T, Nguyen T, Min W, Lee D J Microbiol Biotechnol. 2022; 32(9):1126-1133.

PMID: 36039381 PMC: 9628969. DOI: 10.4014/jmb.2207.07026.

The antiplatelet activity of PMC, a potent alpha-tocopherol analogue, is mediated through inhibition of cyclo-oxygenase.

Sheu J, Lee C, Lin C, Kan Y, Lin C, Hung W Br J Pharmacol. 1999; 127(5):1206-12.

PMID: 10455267 PMC: 1566113. DOI: 10.1038/sj.bjp.0702637.

Obstructive nephropathy in the rat: possible roles for the renin-angiotensin system, prostaglandins, and thromboxanes in postobstructive renal function.

Yarger W, Schocken D, Harris R J Clin Invest. 1980; 65(2):400-12.

PMID: 7356687 PMC: 371378. DOI: 10.1172/JCI109683.

Elevated thromboxane levels in the rat during endotoxic shock: protective effects of imidazole, 13-azaprostanoic acid, or essential fatty acid deficiency.

Cook J, WISE W, Halushka P J Clin Invest. 1980; 65(1):227-30.

PMID: 7350199 PMC: 371359. DOI: 10.1172/JCI109655.

Generation of thromboxane A2 and aorta-contracting activity from platelets stimulated with modified C-reactive protein.

Simpson R, Prancan A, Izzi J, Fiedel B Immunology. 1982; 47(1):193-202.

PMID: 7118160 PMC: 1555513.

References

Hamberg M, Svensson J, Samuelsson B . Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci U S A. 1975; 72(8):2994-8. PMC: 432905. DOI: 10.1073/pnas.72.8.2994. View

Pace-Asciak C . Letter: Isolation, structure, and biosynthesis of 6-ketoprostaglandin F1 alpha in the rat stomach. J Am Chem Soc. 1976; 98(8):2348-9. DOI: 10.1021/ja00424a065. View

Butcher R, SUTHERLAND E . Adenosine 3',5'-phosphate in biological materials. I. Purification and properties of cyclic 3',5'-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3',5'-phosphate in human urine. J Biol Chem. 1962; 237:1244-50. View

Harper J, Brooker G . Femtomole sensitive radioimmunoassay for cyclic AMP and cyclic GMP after 2'0 acetylation by acetic anhydride in aqueous solution. J Cyclic Nucleotide Res. 1975; 1(4):207-18. View

MILLER O, Gorman R . Modulation of platelet cyclic nucleotide content by PGE1 and the prostaglandin endoperoxide PGG2. J Cyclic Nucleotide Res. 1976; 2(2):79-87. View

Isakson P, Raz A, Denny S, Pure E, NEEDLEMAN P . A novel prostaglandin is the major product of arachidonic acid metabolism in rabbit heart. Proc Natl Acad Sci U S A. 1977; 74(1):101-5. PMC: 393205. DOI: 10.1073/pnas.74.1.101. View

Wolfe S, Shulman N . Adenyl cyclase activity in human platelets. Biochem Biophys Res Commun. 1969; 35(2):265-72. DOI: 10.1016/0006-291x(69)90277-0. View

Steiner A, Parker C, KIPNIS D . Radioimmunoassay for cyclic nucleotides. I. Preparation of antibodies and iodinated cyclic nucleotides. J Biol Chem. 1972; 247(4):1106-13. View

Piper P, Vane J . Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs. Nature. 1969; 223(5201):29-35. DOI: 10.1038/223029a0. View

10.

Hamberg M, Samuelsson B . Detection and isolation of an endoperoxide intermediate in prostaglandin biosynthesis. Proc Natl Acad Sci U S A. 1973; 70(3):899-903. PMC: 433384. DOI: 10.1073/pnas.70.3.899. View

11.

Hamberg M, Svensson J, Wakabayashi T, Samuelsson B . Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation. Proc Natl Acad Sci U S A. 1974; 71(2):345-9. PMC: 388001. DOI: 10.1073/pnas.71.2.345. View

12.

Gryglewski R, Vane J . The generation from arachidonic acid of rabbit aorta contracting substance (RCS) by a microsomal enzyme preparation which also generates prostaglandins. Br J Pharmacol. 1972; 46(3):449-57. PMC: 1666543. DOI: 10.1111/j.1476-5381.1972.tb08142.x. View

13.

Nugteren D, Hazelhof E . Isolation and properties of intermediates in prostaglandin biosynthesis. Biochim Biophys Acta. 1973; 326(3):448-61. DOI: 10.1016/0005-2760(73)90145-8. View

14.

Eckenfels A, Vane J . Prostaglandins, oxygen tension and smooth muscle tone. Br J Pharmacol. 1972; 45(3):451-62. PMC: 1666169. DOI: 10.1111/j.1476-5381.1972.tb08101.x. View

15.

Pace-Asciak C, Wolfe L . A novel prostaglandin derivative formed from arachidonic acid by rat stomach homogenates. Biochemistry. 1971; 10(20):3657-64. DOI: 10.1021/bi00796a004. View

16.

Moncada S, Gryglewski R, Bunting S, Vane J . An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature. 1976; 263(5579):663-5. DOI: 10.1038/263663a0. View

17.

FRIEDMAN W, Hirschklau M, Printz M, Pitlick P, Kirkpatrick S . Pharmacologic closure of patent ductus arteriosus in the premature infant. N Engl J Med. 1976; 295(10):526-9. DOI: 10.1056/NEJM197609022951003. View

18.

NEEDLEMAN P, Kulkarni P, Raz A . Coronary tone modulation: formation and actions of prostaglandins, endoperoxides, and thromboxanes. Science. 1977; 195(4276):409-12. DOI: 10.1126/science.831285. View

19.

NEEDLEMAN P, Moncada S, Bunting S, Vane J, Hamberg M, Samuelsson B . Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides. Nature. 1976; 261(5561):558-60. DOI: 10.1038/261558a0. View

20.

Wolfe L, Rostworowski K, Marion J . Endogenous formation of the prostaglandin endoperoxide metabolite, thromboxane B2, by brain tissue. Biochem Biophys Res Commun. 1976; 70(3):907-13. DOI: 10.1016/0006-291x(76)90677-x. View